TWP Logo Healthcare
Experts in Growth
Deep domain expertise, powerful distribution and long-term relationships that produce results.
INVESTMENT BANKING

Nabeel Kaukab

Vice President
Healthcare Investment Banking
+1 212.271.3460
nkaukab@tweisel.com


Nabeel Kaukab is a Vice President in Healthcare Investment Banking at Thomas Weisel Partners with over 9 years of Investment Banking and consulting experience. Based in New York, Nabeel joined the firm in 2008 and focuses on the biopharma, cell therapy, life science tools, and molecular diagnostics subsectors. Prior to joining TWP, Nabeel was an Associate Director in the Global Healthcare Group at UBS Investment Bank and a management consultant for Viant Corporation. Prior to starting his professional career, Nabeel worked in the stem cell research labs of Pablo Rubinstein, New York City Blood Center, and Rajni Aggarwal, Children's Hospital of Cincinnati. Nabeel completed his undergraduate degree in Neuroscience from Columbia University and pursued his graduate studies in Biotechnology at the University of Pennsylvania.
Notable Transactions

Company Name
Ticker Trans. Type Trans. Amt.
(in M)
Trans. Date
Danaher Corporation/Life Technologies (AB Sciex mass spectrometry JV)
LIFE M&A $450.0 USD 2/1/10
Helicos Biosciences
HLCS RD $6.4 USD 12/15/09
Helicos Biosciences
HLCS PIPE $10.0 USD 9/18/09
Pioneer Surgical Technology
-- PP $15.0 USD 12/16/08
Affymetrix, Inc./Panomics, Inc.
-- M&A $74.7 USD 12/5/08
Geron/Exeter Life Sciences (stART Licensing JV)
GERN M&A Undisclosed 8/12/08
Phibro Animal Health
PAHC IPO $45.0 USD 4/4/08
Phibro Animal Health/3i (19.5% Minority Stake)
-- M&A $52.7 USD 3/13/08
American Radiology Services/CML HealthCare
-- M&A $150.4 USD 2/29/08
Pharming
PHARM CVT €70.0 EUR 10/18/07
HealthSpring
HS Other $100.0 USD 10/1/07
Biomet
BMET Other $2,340.0 USD 9/25/07
Biomet
BMET Other $2,565.0 USD 9/25/07
Helicos Biosciences
HLCS IPO $52.2 USD 5/24/07
Matrix Laboratories/Mylan Laboratories
524794 M&A $736.0 USD 1/8/07
Neurochem
NRMX CVT $42.1 USD 11/3/06
HealthSpring
HS FO $220.2 USD 10/4/06
CompManagement/Sedgwick CMS
SCC M&A $191.5 USD 9/13/06
Phibro Animal Health
-- Other $240.0 USD 8/1/06
Phibro Animal Health
-- Other $65.0 USD 8/1/06
HealthSpring
HS Other $75.0 USD 4/21/06
StemCells
STEM PIPE $35.8 USD 4/3/06
Ranbaxy Laboratories
500359 CVT $440.0 USD 2/16/06
HealthSpring
HS IPO $421.6 USD 2/3/06

TWP transactions indicated in bold.